In a new report on omega-3's, market research firm Frost & Sullivan (San Antonio, TX) confirms that the fatty acids will drive consumer demand in the coming years.
In a new report on omega-3's, market research firm Frost & Sullivan (San Antonio, TX) confirms that the fatty acids will drive consumer demand in the coming years.
Frost & Sullivan's report, "Strategic Analysis of the European Marine and Algae Oil Omega-3 Ingredients Market," finds that the market earned revenues of $323 million in 2008 and estimates this to reach $525 million in 2013.
Manufacturers who recognize the link between consumer awareness and product marketability are branding their ingredients on consumer food and beverage products. Meanwhile, the Global Organization of EPA & DHA Omega-3 (GOED), an industry organization, has funded Purdue University in the United States to establish the Omega-3 Learning Consortium for Health and Medicine to provide credible information about omega-3 fatty acids to consumers, health professionals, and the media.
"Industry associations have been successfully formed to protect their interests and voice their opinions to government agencies charged with regulating food ingredients," says Frost & Sullivan research sonsultant Christopher Shanahan. "These associations play a critical role in addressing crucial legislative challenges facing the industry and in providing opportunities that benefit the overall growth of the market."
The projected 10% compound annual growth rate (CAGR) from 2008 to 2013 in the marine and algae oil omega-3 ingredient market is likely to jump-start key condition-specific health markets such as cognitive health, joint health, and immune health; however, the omega-3 industry is facing an increasingly complex set of technological, environmental, and regulatory changes.
"On February 12, 2010, the European Parliament approved nutrition claims for omega-3s allowing food products to claim they are either a 'source of omega-3 fatty acids' or that they contain 'high omega-3 fatty acids'," notes Shanahan. "This is a positive development because it will enhance both consumer awareness and usage across Europe, in countries where consumers already understand the value of omega-3s."
Despite these favourable conditions, participants have a lot of ground to cover with regard to awareness and acceptance. They have been greatly assisted in their endeavours by positive media coverage. They have also benefited from an aging population that is more predisposed to chronic illness such as cardiac disorders, strokes, osteoporosis, and cancers.
"A larger number of consumers consider food products an alternative means to prevent many diseases and adverse health conditions such as cardiovascular disease," observes Shanahan. "The demand for omega-3 ingredients is directly related to the escalating incidence of cardiovascular disease in developed countries and it significantly hikes the unit consumption."
Original Source: Frost & Sullivan
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.